Jovan-Embiricos Morana 4
4 · Kalaris Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Jovan-Embiricos Morana
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-10+18,000→ 18,000 totalExercise: $7.31Exp: 2035-04-09→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments from March 18, 2025 through March 18, 2028, subject to continuous service.